Using biology to guide radiotherapy, we hope to have the means to turn cancer on itself. By leveraging positron emission tomography (PET), the gold standard in cancer imaging and staging in a novel way, RefleXion's patented technology* causes tumors to continuously signal their location during radiotherapy delivery, potentially transforming radiotherapy from an early stage, local therapy into one suitable for metastatic disease. We are passionately committed to making dramatic changes to cancer care, and we believe that small, lean teams of brilliant people are the only way to do that. We need teammates with both the career and foresight experience to avoid roadblocks, and we hope to have the means to turn cancer on itself. If we want to help you create a game that is constantly evolving and creatively and creatively, please join us. If you want to learn more about the current and unchanging modality of cancer care, please visit SBRT/RTX.